keyword
https://read.qxmd.com/read/38635623/distribution-and-genotyping-of-hepatitis-c-virus-hcv-infection-in-gansu-province-china
#1
JOURNAL ARTICLE
Qiajun Du, Xinghong Wu, Linmei Chen, Youli Zhao, Hongwei Gao, Yan Fen, Shangdi Zhang, Shan Gao
INTRODUCTION: The distribution of common subtypes of hepatitis C virus (HCV) in Gansu province were analyzed. This information provided a theoretical basis for the selection of appropriate antiviral treatment regimens. METHODOLOGY: We collected data on HCV antibody screening tests from 421,802 outpatients and inpatients at the Second Clinical Hospital of Lanzhou University from January 2018 to June 2022. Ribonucleic acid (RNA) viral load, HCV genotypes, and HCV quantification were analyzed retrospectively...
March 31, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38635621/treatment-initiation-rates-of-patients-with-positive-anti-hepatitis-c-virus-results-in-tertiary-hospitals-in-turkey
#2
JOURNAL ARTICLE
Mustafa K Çelen, Buket Ertürk Şengel, Şafak Kaya, Neşe Demirtürk, Alpay Azap, Hüsnü Pullukçu, Esma Eroğlu, Figen Yıldırım, Hüseyin Ş Barut, Esra Zerdali, Ayşe Sağmak Tartar, Ayşe Ö Mete, Ahmet M Şahin, Bedia Mutay Suntur, Nagehan D Sarı, Emel Yılmaz, Aslıhan Candevir, Funda Şimşek, Dilara İnan, Sıla Akhan, Ali Asan, Özgür Günal, Onur Ural, Mehmet Parlak, Mehmet Çabalak, Selçuk Nazik, Kenan Hızel, Sami Kınıklı, Zehra Beştepe Dursun, Ayşe Batırel, Çiğdem Mermutluoğlu
INTRODUCTION: The aim of this national, multicenter, cross-sectional, retrospective chart review study was to determine the proportion of patients in Turkey who received hepatitis C virus (HCV) treatment after receiving positive anti-HCV results during HCV screening. METHODOLOGY: Data related to patients' demographics, laboratory results, time interval from obtaining a positive anti-HCV result to treatment initiation, specialty of the physician requesting anti-HCV screening, and type of hospital were analyzed...
March 31, 2024: Journal of Infection in Developing Countries
https://read.qxmd.com/read/38633970/acute-hepatitis-e-virus-infection-triggering-autoimmune-hepatitis-in-a-patient-with-chronic-liver-disease-case-report-and-the-review-of-the-literature
#3
Sayan Malakar, Nishant Shah, Ankit Mishra, Vipin Pandey, Vivek V Shirol, Naganath K Wodeyar, Prabhat Verma, Sai Prathap, Kartik Balankhe, Ramnawal Rao, Uday C Ghoshal
Acute viral hepatitis E (HEV) is the most common form of acute viral hepatitis in India. It is associated with self-limiting disease in most cases. However, the chronic form of HEV is also being increasingly recognized. Other viral infections like the hepatitis A virus (HAV) have been implicated in inciting autoimmune hepatitis. HEV infection has been associated with the formation of circulating liver-directed autoantibodies, however autoimmune liver disease following acute HEV infection has been rarely reported...
March 2024: Curēus
https://read.qxmd.com/read/38633576/sex-and-gender-differences-in-hepatitis-c-virus-risk-prevention-and-cascade-of-care-in-people-who-inject-drugs-systematic-review-and-meta-analysis
#4
JOURNAL ARTICLE
Anna Levinsson, Camille Zolopa, Farzaneh Vakili, Sasha Udhesister, Nadine Kronfli, Mathieu Maheu-Giroux, Julie Bruneau, Heather Valerio, Sahar Bajis, Phillip Read, Elisa Martró, Lisa Boucher, Leith Morris, Jason Grebely, Adelina Artenie, Jack Stone, Peter Vickerman, Sarah Larney
BACKGROUND: People who inject drugs (PWID) are a priority population in HCV elimination programming. Overcoming sex and gender disparities in HCV risk, prevention, and the cascade of care is likely to be important to achieving this goal, but these have not yet been comprehensively reviewed. METHODS: Systematic review and meta-analysis. We searched Pubmed, EMBASE and the Cochrane Database of Systematic Reviews 1 January 2012-22 January 2024 for studies of any design reporting sex or gender differences among PWID in at least one of: sharing of needles and/or syringes, incarceration history, injection while incarcerated, participation in opioid agonist treatment or needle and syringe programs, HCV testing, spontaneous HCV clearance, direct-acting antiviral (DAA) treatment initiation or completion, and sustained virological response (SVR)...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38631661/a-mutual-regulatory-loop-between-transcription-factor-yin-yang-1-and-hepatitis-b-virus-replication-influences-chronic-hepatitis-b-1
#5
JOURNAL ARTICLE
Jie Zhou, Yunhao Hua, Yuwei Liu, Tong Wu, Hongqin Xu, Zhongfeng Wang, Xiaomei Wang, Junqi Niu
Hepatitis B virus (HBV) infections pose a major threat to human health. HBV can upregulate the expression of the transcription factor Yin Yang 1 (YY1) in in vitro cytological experiments, suggesting an association between YY1 and HBV infection. However, data on YY1 expression in chronic hepatitis B (CHB) patients are lacking. In this study, we aimed to assess the correlation between YY1 expression and HBV infection. We detected serum YY1 levels in 420 patients with chronic HBV infection, 30 patients with chronic hepatitis C virus infection, and 32 healthy controls using an enzyme-linked immunosorbent assay...
April 15, 2024: Antiviral Research
https://read.qxmd.com/read/38631259/a-novel-epigenetic-strategy-to-concurrently-block-immune-checkpoints-pd-1-pd-l1-and-cd155-tigit-in-hepatocellular-carcinoma
#6
JOURNAL ARTICLE
Reem A Assal, Noha M Elemam, Radwa Y Mekky, Abdelrahman A Attia, Aya Hesham Soliman, Asmaa Ibrahim Gomaa, Eleni K Efthimiadou, Maria Braoudaki, Sherif Ashraf Fahmy, Rana A Youness
Tumor microenvironment is an intricate web of stromal and immune cells creating an immune suppressive cordon around the tumor. In hepatocellular carcinoma (HCC), Tumor microenvironment is a formidable barrier towards novel immune therapeutic approaches recently evading the oncology field. In this study, the main aim was to identify the intricate immune evasion tactics mediated by HCC cells and to study the epigenetic modulation of the immune checkpoints; Programmed death-1 (PD-1)/ Programmed death-Ligand 1 (PD-L1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT)/Cluster of Differentiation 155 (CD155) at the tumor-immune synapse...
April 16, 2024: Translational Oncology
https://read.qxmd.com/read/38630939/needle-and-syringe-sharing-among-people-who-have-recently-injected-drugs-in-australia-the-ethos-engage-study
#7
JOURNAL ARTICLE
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham
INTRODUCTION: Understanding needle/syringe sharing is crucial for reducing hepatitis C virus (HCV) infection and reinfection. This study aimed to assess the prevalence and factors associated with needle/syringe sharing among people who inject drugs in Australia, including those previously receiving HCV treatment. METHODS: The ETHOS Engage study was an observational cohort study which collected self-reported survey data on demographic and drug use information from people who inject drugs attending drug treatment clinics and needle and syringe programs over two waves between May 2018 and June 2021...
April 17, 2024: Drug and Alcohol Review
https://read.qxmd.com/read/38630853/forecasting-hepatitis-c-virus-status-for-children-in-the-united-states-a-modeling-study
#8
JOURNAL ARTICLE
Robert B Hood, Alison H Norris, Abigail Shoben, William C Miller, Randall E Harris, Laura W Pomeroy
BACKGROUND: Virtually all cases of hepatitis C virus (HCV) infection in children in the United States occur through vertical transmission, but it is unknown how many children are infected. Cases of maternal HCV infection have increased in the United States, which may increase the number of children vertically infected with HCV. Infection has long-term consequences for a child's health, but treatment options are now available for children ≥3 years old. Reducing HCV infections in adults could decrease HCV infections in children...
April 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38630782/characterization-of-the-brain-virome-in-human-immunodeficiency-virus-infection-and-substance-use-disorder
#9
JOURNAL ARTICLE
Xin Dang, Barbara A Hanson, Zachary S Orban, Millenia Jimenez, Stephen Suchy, Igor J Koralnik
Viruses can infect the brain in individuals with and without HIV-infection: however, the brain virome is poorly characterized. Metabolic alterations have been identified which predispose people to substance use disorder (SUD), but whether these could be triggered by viral infection of the brain is unknown. We used a target-enrichment, deep sequencing platform and bioinformatic pipeline named "ViroFind", for the unbiased characterization of DNA and RNA viruses in brain samples obtained from the National Neuro-AIDS Tissue Consortium...
2024: PloS One
https://read.qxmd.com/read/38630548/monitoring-hepatocellular-carcinoma-using-tumor-content-in-circulating-cell-free-dna
#10
JOURNAL ARTICLE
Shifeng Lian, Chenyu Lu, Fugui Li, Xia Yu, Limei Ai, Biao-Hua Wu, Xueyi Gong, Wenjing Zhou, Xuejun Liang, Jiyun Zhan, Yong Yuan, Fang Fang, Zhiwei Liu, Mingfang Ji, Zongli Zheng
PURPOSE: To evaluate the utility of tumor content in circulating cell-free DNA (ccfDNA) for monitoring hepatocellular carcinoma (HCC) throughout its natural history. METHODS: We included 67 hepatitis B virus (HBV)-related HCC patients, of whom 17 had paired pre- and post-treatment samples, and 90 controls. Additionally, in a prospective cohort with HBV surface antigen-positive participants recruited in 2012 and followed up biannually with blood sample collections until 2019, we included 270 repeated samples before diagnosis from 63 participants who later developed HCC (pre-HCC samples)...
April 17, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38629837/the-impact-of-hbx-protein-on-mitochondrial-dynamics-and-associated-signaling-pathways-strongly-depends-on-the-hepatitis-b-virus-genotype
#11
JOURNAL ARTICLE
Anja Schollmeier, Michael Basic, Mirco Glitscher, Eberhard Hildt
Chronic hepatitis B virus (HBV) infections are strongly associated with liver cirrhosis, inflammation, and hepatocellular carcinoma. In this context, the viral HBx protein is considered as a major factor influencing HBV-associated pathogenesis through deregulation of multiple cellular signaling pathways and is therefore a potential target for prognostic and therapeutic applications. However, HBV-associated pathogenesis differs significantly between genotypes, with the relevant factors and in particular the contribution of the genetic diversity of HBx being largely unknown...
April 17, 2024: Journal of Virology
https://read.qxmd.com/read/38628422/high-seroprevalence-of-hepatitis-e-virus-in-the-free-state-province-of-south-africa
#12
JOURNAL ARTICLE
Sindiswa S Maphumulo, Dominique Goedhals, Cornel van Rooyen, Sabeehah Vawda
UNLABELLED: The seroepidemiology of hepatitis E virus (HEV) in South Africa is limited. We investigated anti-HEV IgM and IgG, in residual hepatitis A, B, and C negative serology specimens, at our public sector Free State (FS) laboratory. Of 299 specimens (01 May-31 October 2020), 182/299 (60.9%) had anti-HEV IgG and 1/299 (0.33%) had anti-HEV IgM. High HEV seroprevalence across different age groups suggests a different epidemiology in the FS, necessitating further research. CONTRIBUTION: The need for HEV research in South Africa is highlighted...
2024: Southern African Journal of Infectious Diseases
https://read.qxmd.com/read/38628243/seroprevalence-of-hepatitis-b-and-c-viruses-and-their-associated-factors-among-military-personnel-at-military-camps-in-central-gondar-ethiopia-a-cross-sectional-study
#13
JOURNAL ARTICLE
Ayanaw Dinku Abebe, Muluneh Assefa, Debaka Belete, Getachew Ferede
BACKGROUND: Globally, viral hepatitis is a leading cause of death and is highly prevalent in Ethiopia. Military personnel are more vulnerable to hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, and there are no data on such populations in the study area. Therefore, this study aimed to determine the seroprevalence of HBV and HCV infections and their associated factors among military personnel in military camps in Central Gondar, Ethiopia. MATERIALS AND METHODS: This institutional-based cross-sectional study was conducted with 277 military personnel from April to August 2022 at military camps in Central Gondar, Ethiopia...
2024: Infection and Drug Resistance
https://read.qxmd.com/read/38626232/hepatitis-b-and-hepatitis-c-virus-infections-and-associated-factors-among-prisoners-in-gondar-city-northwest-ethiopia
#14
JOURNAL ARTICLE
Kebebe Tadesse, Getnet Ayalew, Yihenew Million, Aschalew Gelaw
BACKGROUND: Globally, hepatitis B virus (HBV) and hepatitis C virus (HCV) cause considerable morbidity and mortality from their acute and chronic infections. The transmission of the viruses within the prisons is high due to overcrowding, and other risk behaviors such as drug use, and unsafe sexual practices. This study aimed at determining the prevalence and associated factors of HBV and HCV infections among prisoners in Gondar city, Northwest Ethiopia. METHODS: A cross-sectional study was conducted in the Gondar City Prison Center from May 1, 2022, to July 30, 2022...
2024: PloS One
https://read.qxmd.com/read/38626190/how-robust-are-estimates-of-key-parameters-in-standard-viral-dynamic-models
#15
JOURNAL ARTICLE
Carolin Zitzmann, Ruian Ke, Ruy M Ribeiro, Alan S Perelson
Mathematical models of viral infection have been developed, fitted to data, and provide insight into disease pathogenesis for multiple agents that cause chronic infection, including HIV, hepatitis C, and B virus. However, for agents that cause acute infections or during the acute stage of agents that cause chronic infections, viral load data are often collected after symptoms develop, usually around or after the peak viral load. Consequently, we frequently lack data in the initial phase of viral growth, i.e...
April 16, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38622549/hepatitis-c-screening-in-lithuania-first-year-results-and-scenarios-for-achieving-who-elimination-targets
#16
JOURNAL ARTICLE
Janina Petkevičienė, Alexis Voeller, Eglė Čiupkevičienė, Devin Razavi-Shearer, Valentina Liakina, Ligita Jančorienė, Edita Kazėnaitė, Viačeslavas Zaksas, Gediminas Urbonas, Limas Kupčinskas
BACKGROUND: The World Health Organization (WHO) has outlined a set of targets to achieve eliminating hepatitis C by 2030. In May 2022, Lithuanian health authorities initiated a hepatitis C virus (HCV) screening program to start working towards elimination. In the program, bonus was given to general practitioners (GPs) to promote and conduct anti-HCV tests for two situations: (1) one time testing for individuals born in 1945-1994 and (2) annual HCV testing for persons who inject drugs or are living with human immunodeficiency virus (HIV) regardless of age...
April 15, 2024: BMC Public Health
https://read.qxmd.com/read/38621559/in-silico-design-of-a-novel-multi-epitope-vaccine-against-hcv-infection-through-immunoinformatics-approaches
#17
JOURNAL ARTICLE
Sajjad Ahmad, Fatemeh Mobini Demneh, Bushra Rehman, Taghreed N Almanaa, Nahid Akhtar, Hamidreza Pazoki-Toroudi, Ali Shojaeian, Mahdi Ghatrehsamani, Samira Sanami
Infection with the hepatitis C virus (HCV) is one of the causes of liver cancer, which is the world's sixth most prevalent and third most lethal cancer. The current treatments do not prevent reinfection; because they are expensive, their usage is limited to developed nations. Therefore, a prophylactic vaccine is essential to control this virus. Hence, in this study, an immunoinformatics method was applied to design a multi-epitope vaccine against HCV. The best B- and T-cell epitopes from conserved regions of the E2 protein of seven HCV genotypes were joined with the appropriate linkers to design a multi-epitope vaccine...
April 13, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38621170/hepatitis-c-exposure-diagnosis-and-testing-in-infants-born-to-hepatitis-c-virus-infected-mothers
#18
JOURNAL ARTICLE
Natalie Morris, Krystal Hunter, Vishwanath Bhat, Alla Kushnir
BACKGROUND: There has been a 5-fold increase in the number of cases of hepatitis C virus (HCV) infection among pregnant women, which is potentially associated with the increase in opioid use. METHODS: This study was a retrospective review of infants born at a tertiary urban hospital in New Jersey, from January 1, 2011 to January 1, 2021, who were born to mothers with a prenatal diagnosis of HCV. RESULTS: Of the 142 mothers with a prenatal diagnosis of HCV, 114 (80%) infants had a diagnosis of HCV exposure in the electronic health records...
April 10, 2024: Pediatric Infectious Disease Journal
https://read.qxmd.com/read/38619807/hepatitis-c-virus-core-antigen-a-diagnostic-and-treatment%C3%A2-monitoring-marker-of-hepatitis-c-virus-in-indian-population
#19
JOURNAL ARTICLE
Jaya Garg, Prashant Verma, Mridu Singh, Anupam Das, Anurag Pathak, Jyotsna Agarwal
BACKGROUND: The diagnosis and treatment monitoring of hepatitis C is quite challenging. The screening test, i.e. antibody assay, is unable to detect acute cases, while the gold standard hepatitis C virus (HCV) reverse transcriptase polymerase chain reaction (RTPCR) assay is not feasible in resource-limited countries such as India due to high cost and infrastructure requirement. European Association for the Study of the Liver and World Health Organization have approved a new marker, i...
April 15, 2024: Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology
https://read.qxmd.com/read/38619622/molecular-characterization-of-the-nonstructural-5a-ns5a-region-of-hepatitis-c-virus-in-thai-blood-donors
#20
JOURNAL ARTICLE
Anchalee Sistayanarain, Duangkamol Kunthalert
Direct acting antivirals (DAAs) have been developed for hepatitis C virus (HCV) therapy, and they are usually effective, however resistance to DAA regimens has also been reported to have a significant impact. Resistance associated substitutions (RASs) in the NS5A region are known to be correlated with failure of DAA therapy. HCV genotypes 3a and 1 are the most prevalent genotypes in Thailand. This study analyzed the type and frequency of RASs associated with DAA failure, focusing on the NS5A region. Serum samples of HCV genotype 3a, 1a, and 1b infection from Thai blood donors were selected...
April 15, 2024: Archives of Microbiology
keyword
keyword
18361
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.